What is Ventrk?
Ventrk is a technology company focused on developing software solutions designed to empower better decision-making and drive improved results for a healthier lifestyle. Its core offering, the TheraCentric platform, is a comprehensive therapy management system engineered to streamline practice activities and enhance patient engagement. This positions Ventrk within the health-tech and digital wellness sectors, addressing critical needs in practice efficiency and patient care.
How much funding has Ventrk raised?
Ventrk has raised a total of $1.9M across 2 funding rounds:
Angel/Seed
$900K
Unspecified
$1M
Angel/Seed (2022): $900K, investors not publicly disclosed
Unspecified (2022): $1M led by HBSI Capital
Key Investors in Ventrk
HBSI Capital
HBSI Capital is an investment and management consulting firm focused on organizational growth. They provide investment and guidance at the board level, with a preference for existing leadership to continue running the business, and offer mentorship to executive teams.
What's next for Ventrk?
The recent major strategic investment signals a pivotal moment for Ventrk, suggesting a focus on accelerating product development, expanding market penetration, and potentially forging new strategic partnerships. With a clear trajectory from its initial seed funding to this significant capital infusion, Ventrk is poised to further solidify its position in the competitive health-tech landscape, aiming for sustained growth and impact in empowering healthier lifestyles through advanced software.
See full Ventrk company page
